| Style | Citing Format |
|---|---|
| MLA | Rokhsati S, et al.. "High-Intensity Interval and Aerobic Training Alleviate Cardiac Pathology, Apoptosis, and Atrial Fibrillation in Rats With Chronic Kidney Disease: The Roles of Fgf23 and Klotho." Biomolecules, vol. 16, no. 4, 2026, pp. -. |
| APA | Rokhsati S, Shahsavari N, Rabbani S, Suzuki K, Khoramipour K (2026). High-Intensity Interval and Aerobic Training Alleviate Cardiac Pathology, Apoptosis, and Atrial Fibrillation in Rats With Chronic Kidney Disease: The Roles of Fgf23 and Klotho. Biomolecules, 16(4), -. |
| Chicago | Rokhsati S, Shahsavari N, Rabbani S, Suzuki K, Khoramipour K. "High-Intensity Interval and Aerobic Training Alleviate Cardiac Pathology, Apoptosis, and Atrial Fibrillation in Rats With Chronic Kidney Disease: The Roles of Fgf23 and Klotho." Biomolecules 16, no. 4 (2026): -. |
| Harvard | Rokhsati S et al. (2026) 'High-Intensity Interval and Aerobic Training Alleviate Cardiac Pathology, Apoptosis, and Atrial Fibrillation in Rats With Chronic Kidney Disease: The Roles of Fgf23 and Klotho', Biomolecules, 16(4), pp. -. |
| Vancouver | Rokhsati S, Shahsavari N, Rabbani S, Suzuki K, Khoramipour K. High-Intensity Interval and Aerobic Training Alleviate Cardiac Pathology, Apoptosis, and Atrial Fibrillation in Rats With Chronic Kidney Disease: The Roles of Fgf23 and Klotho. Biomolecules. 2026;16(4):-. |
| BibTex | @article{ author = {Rokhsati S and Shahsavari N and Rabbani S and Suzuki K and Khoramipour K}, title = {High-Intensity Interval and Aerobic Training Alleviate Cardiac Pathology, Apoptosis, and Atrial Fibrillation in Rats With Chronic Kidney Disease: The Roles of Fgf23 and Klotho}, journal = {Biomolecules}, volume = {16}, number = {4}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Rokhsati S AU - Shahsavari N AU - Rabbani S AU - Suzuki K AU - Khoramipour K TI - High-Intensity Interval and Aerobic Training Alleviate Cardiac Pathology, Apoptosis, and Atrial Fibrillation in Rats With Chronic Kidney Disease: The Roles of Fgf23 and Klotho JO - Biomolecules VL - 16 IS - 4 SP - EP - PY - 2026 ER - |